[1]
2014. Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis . Clinics. 69, 8 (Aug. 2014), 547–553. DOI:https://doi.org/10.6061/clinics/2014(08)08.